Ajanta Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

1,959.76

1,687.52

1,574.21

1,566.43

1,237.36

Operating profit

557.52

347.04

425.02

465.87

424.27

Interest

3.02

1.34

7.88

1.24

2.55

Gross profit

631.15

459.49

473.46

548.04

521.06

EPS (Rs)

33.59

24.70

38.39

44.89

38.87

Other income

76.65

113.79

56.32

83.41

99.34

Stock adjustment

6.24

30.19

-67.65

11.05

-66.91

Raw material

441.36

400.46

415.62

357.42

340.92

Power and fuel

-

-

-

-

-

Employee expenses

401.78

337.82

294.01

291.86

241.98

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

552.86

572.01

507.21

440.23

297.10

Provisions made

-

-

-

-

-

Depreciation

65.28

62.55

60.80

60.16

54.06

Taxation

141.47

79.39

83.11

97.57

126.09

Net profit / loss

424.40

317.55

329.55

390.31

340.91

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

25.27

25.71

17.17

17.39

17.54

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

28.45

20.57

27.00

29.74

34.29

GPM (%)

30.99

25.51

29.04

33.22

38.98

NPM (%)

20.84

17.63

20.21

23.66

25.50